Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-14 Sale | 2026-05-15 4:08 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 403 | $9.5 | $3,829 | 94,821 (Direct) | View |
| 2026-05-14 Sale | 2026-05-15 4:07 pm | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 408 | $9.5 | $3,876 | 56,829 (Direct) | View |
| 2026-05-14 Sale | 2026-05-15 4:05 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 324 | $9.5 | $3,078 | 107,940 (Direct) | View |
| 2026-05-14 Sale | 2026-05-15 4:04 pm | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 53 | $9.5 | $504 | 23,801 (Direct) | View |
| 2026-05-14 Sale | 2026-05-15 4:03 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 2,203 | $9.5 | $20,929 | 269,747 (Direct) | View |
| 2026-05-14 Sale | 2026-05-15 4:02 pm | Karyopharm Therapeutics Inc. | KPTI | Mano Michael EVP, CLO&Secretary | 266 | $9.5 | $2,527 | 94,398 (Direct) | View |
| 2026-04-21 Sale | 2026-04-22 4:03 pm | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 449 | $8.94 | $4,014 | 56,290 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 4:29 pm | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 559 | $9.4095 | $5,260 | 22,063 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 4:28 pm | Karyopharm Therapeutics Inc. | KPTI | Mano Michael EVP, CLO&Secretary | 3,526 | $9.4095 | $33,178 | 93,964 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 4:27 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 4,604 | $9.4095 | $43,321 | 107,317 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 4:25 pm | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 5,066 | $9.4095 | $47,669 | 56,739 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 4:21 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 12,361 | $9.4095 | $116,311 | 267,030 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 4:17 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 5,101 | $9.4095 | $47,998 | 94,328 (Direct) | View |
| 2026-02-17 Sale | 2026-02-19 4:02 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 378 | $8.63 | $3,262 | 99,429 (Direct) | View |
| 2026-02-03 Sale | 2026-02-04 4:11 pm | Karyopharm Therapeutics Inc. | KPTI | Macomber Lori EVP, CFO & Treasurer | 1,626 | $6.3 | $10,244 | 85,105 (Direct) | View |
| 2026-01-28 Sale | 2026-01-29 4:57 pm | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 50 | $7.03 | $352 | 22,622 (Direct) | View |
| 2026-01-21 Sale | 2026-01-22 4:09 pm | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 265 | $5.96 | $1,579 | 22,580 (Direct) | View |
| 2025-10-01 Sale | 2025-10-03 4:56 pm | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 362 | $6.296 | $2,279 | 10,046 (Direct) | View |
| 2025-09-15 Sale | 2025-09-16 4:35 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 1,257 | $6.43 | $8,083 | 84,046 (Direct) | View |
| 2025-09-15 Sale | 2025-09-16 4:34 pm | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 234 | $6.43 | $1,505 | 21,425 (Direct) | View |
| 2025-09-15 Sale | 2025-09-16 4:33 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 401 | $6.43 | $2,578 | 27,710 (Direct) | View |
| 2025-09-15 Sale | 2025-09-16 4:32 pm | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 408 | $6.43 | $2,623 | 29,390 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-21 Option Award | 2026-05-26 4:17 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Oliger Christy J. Director | 15,508 | $0 | 15,508 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:15 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director | 15,508 | $0 | 15,508 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:14 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Schor Chen Director | 15,508 | $0 | 15,508 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:13 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Su Zhen Director | 15,508 | $0 | 15,508 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:12 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | BOHLIN GAREN G Director | 15,508 | $0 | 18,517 (Direct) | View |
| 2026-05-21 Option Award | 2026-05-26 4:06 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Greene Barry E Director | 15,508 | $0 | 16,415 (Direct) | View |
| 2026-05-13 Option Award | 2026-05-15 4:08 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 896 | $0 | 94,821 (Direct) | View |
| 2026-05-13 Option Award | 2026-05-15 4:07 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 947 | $0 | 56,829 (Direct) | View |
| 2026-05-13 Option Award | 2026-05-15 4:05 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 947 | $0 | 107,940 (Direct) | View |
| 2026-05-13 Option Award | 2026-05-15 4:04 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 121 | $0 | 23,801 (Direct) | View |
| 2026-05-13 Option Award | 2026-05-15 4:03 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 4,920 | $0 | 269,747 (Direct) | View |
| 2026-05-13 Option Award | 2026-05-15 4:02 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Mano Michael EVP, CLO&Secretary | 700 | $0 | 94,398 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-09 4:11 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 81,060 | $0 | 279,391 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-03 4:32 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 32,415 | $0 | 111,921 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-03 4:31 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 32,415 | $0 | 61,805 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-03 4:29 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Macomber Lori EVP, CFO & Treasurer | 32,415 | $0 | 86,731 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-03 4:28 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Mano Michael EVP, CLO&Secretary | 32,415 | $0 | 97,490 (Direct) | View |
| 2026-01-31 Option Award | 2026-02-03 4:27 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 32,415 | $0 | 99,807 (Direct) | View |
| 2026-01-27 Option Award | 2026-01-29 4:57 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 92 | $0 | 22,622 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-16 4:33 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 12,799 | $0 | 22,845 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-16 4:32 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 39,682 | $0 | 67,392 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-16 4:30 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 43,650 | $0 | 65,075 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-16 4:29 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 114,285 | $0 | 198,331 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-16 4:28 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 43,650 | $0 | 79,506 (Direct) | View |
| 2025-10-15 Option Award | 2025-10-16 4:25 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Macomber Lori EVP, CFO & Treasurer | 43,650 | $0 | 54,316 (Direct) | View |
| 2025-09-12 Option Award | 2025-09-16 4:35 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 2,800 | $0 | 84,046 (Direct) | View |
| 2025-09-12 Option Award | 2025-09-16 4:34 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 612 | $0 | 21,425 (Direct) | View |
| 2025-09-12 Option Award | 2025-09-16 4:33 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 888 | $0 | 27,710 (Direct) | View |
| 2025-09-12 Option Award | 2025-09-16 4:32 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 945 | $0 | 29,390 (Direct) | View |